Psychoses in Parkinson's Disease.

Area of Science:

• Neurology
• Psychiatry

Background:

• Psychotic symptoms affect up to 40% of Parkinson's disease (PD) patients.
• These symptoms often occur with pharmacologic treatment but can manifest independently.
• Psychosis in PD is linked to illness deterioration and reduced quality of life.

Purpose of the Study:

• To review and categorize the six main psychotic syndromes observed in Parkinson's disease.
• To critically evaluate existing literature on the treatment of psychosis in PD.
• To highlight the need for further research into PD-related psychosis.

Main Methods:

• Literature review of existing studies on psychotic disorders in Parkinson's disease.
• Classification of six distinct psychotic syndromes based on clinical presentation and context.
• Critical analysis of treatment approaches, focusing on atypical antipsychotics.

Main Results:

• Identified six psychotic syndromes in PD: hallucinations with insight, medication-induced psychosis, delirium, schizophrenia-like psychosis, schizophrenia with PD, and other disorders.
• Existing literature on treatment is limited but suggests potential efficacy of atypical antipsychotics.
• Psychosis is a significant marker for PD progression and impacts patient well-being.

Conclusions:

• Psychosis presents in various forms in Parkinson's disease, impacting patients and families.
• Atypical antipsychotics show promise for managing PD-related psychosis.
• Further research is crucial to understand the phenomenology, pathophysiology, and optimal treatment of psychosis in PD.